Welcome to LookChem.com Sign In|Join Free
  • or
1-Isopropyl-6-oxo-1,6-dihydropyridine-3-boronic Acid Pinacol Ester is a boron-containing organic compound that is part of the pyridine and its derivatives class. It is characterized by its ability to participate in various coupling reactions, facilitating the formation of carbon-carbon bonds, which is crucial in organic synthesis.

1349151-98-9

Post Buying Request

1349151-98-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1349151-98-9 Usage

Uses

Used in Pharmaceutical Industry:
1-Isopropyl-6-oxo-1,6-dihydropyridine-3-boronic Acid Pinacol Ester is used as a synthetic reagent for the production of various drugs. Its role in coupling reactions allows for the creation of complex molecular structures that are essential in medicinal chemistry, contributing to the development of new pharmaceuticals.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Isopropyl-6-oxo-1,6-dihydropyridine-3-boronic Acid Pinacol Ester serves as a key intermediate in the synthesis of pesticides. Its reactivity in organic synthesis aids in the production of effective compounds for pest control, enhancing crop protection strategies.
Used in Material Science:
1-Isopropyl-6-oxo-1,6-dihydropyridine-3-boronic Acid Pinacol Ester has potential applications in the development of new materials. Its unique properties as a boron-containing compound can be leveraged to create innovative materials with specific characteristics for various applications.
Used as a Building Block in Organic Synthesis:
1-Isopropyl-6-oxo-1,6-dihydropyridine-3-boronic Acid Pinacol Ester is also used as a building block in the synthesis of complex organic molecules. Its versatility in forming carbon-carbon bonds makes it a valuable component in the assembly of intricate organic structures for research and industrial applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1349151-98-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,9,1,5 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1349151-98:
(9*1)+(8*3)+(7*4)+(6*9)+(5*1)+(4*5)+(3*1)+(2*9)+(1*8)=169
169 % 10 = 9
So 1349151-98-9 is a valid CAS Registry Number.

1349151-98-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

1.2 Other means of identification

Product number -
Other names 1-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1349151-98-9 SDS

1349151-98-9Relevant academic research and scientific papers

TRIAZOLO-PYRIMIDINE COMPOUNDS AND USES THEREOF

-

, (2020/05/07)

The present disclosure relates to novel triazolo-pyrimidine compounds targeting adenosine receptors (especially A1 and A2, particularly A2a). The present disclosure also relates to pharmaceutical compositions comprising one or more of the compounds as an active ingredient, and use of the compounds in the treatment of adenosine receptor (AR) associated diseases, for example cancer such as NSCLC, RCC, prostate cancer, and breast cancer.

PYRIDINONE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS

-

, (2019/06/11)

The invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Substituted arylamine compound as well as preparation method and purpose thereof

-

, (2019/10/01)

The invention relates to a substituted arylamine compound as well as a preparation method and a purpose thereof, and particularly relates to the substituted arylamine compound, a pharmacologically acceptable salt, a stereisomer, a polymorphic substance, a

Substituted thiazole derivative and application thereof

-

Paragraph 0150-0152; 0159-0160, (2019/02/13)

The invention provides a compound represented by a general formula (I), or a stereoisomer, pharmaceutically acceptable salt, solvate, hydrate, chemically protective form or prodrug thereof. The compound has an effect of inhibiting adenosine receptor 2a (A2a), and can be used as an antagonist of the adenosine receptor 2a (A2A) for treating tumors.

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

-

, (2011/12/02)

The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various dis

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

-

, (2011/12/02)

The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I wherein the variables are as defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1349151-98-9